P.RamasundarahettigeC.BranchK
It works on two receptors simultaneously, GLP-1 and GIP (glucose-dependent insulinotropic polypeptide), which gives it a dual-action effect
Do not increase the dose on your own

GLP-1 Targeted Peptide Weight Loss Drugs Market Share, by BMI Category, 20242034 Figure 9: Canada GLP-1 Targeted Peptide Weight Loss Drugs Market Share, by Segments, 20242034 Figure 10: Mexico GLP-1 Targeted Peptide Weight Loss Drugs Market Share, by Segments, 20242034 Figure 11: Germany GLP-1 Targeted Peptide Weight Loss Drugs Market Share, by Drug, 20242034 Figure 12: France GLP-1 Targeted Peptide Weight Loss Drugs Market Share, by Segments, 20242034 Figure 13: UK GLP-1 Targeted Peptide Weight Loss Drugs Market Share, by Segments, 20242034 Figure 14: Italy GLP-1 Targeted Peptide Weight Loss Drugs Market Share, by Segments, 20242034 Figure 15: China GLP-1 Targeted Peptide Weight Loss Drugs Market Share, by Drug, 20242034 Figure 16: Japan GLP-1 Targeted Peptide Weight Loss Drugs Market Share, by Segments, 20242034 Figure 17: South Korea GLP-1 Targeted Peptide Weight Loss Drugs Market Share, by Segments, 20242034 Figure 18: India GLP-1 Targeted Peptide Weight Loss Drugs Market Share, by Segments, 20242034 Figure 19: Brazil GLP-1 Targeted Peptide Weight Loss Drugs Market Share, by Segments, 20242034 Figure 20: GCC Countries GLP-1 Targeted Peptide Weight Loss Drugs Market Share, by Segments, 20242034 Figure 21: Turkey GLP-1 Targeted Peptide Weight Loss Drugs Market Share, by Segments, 20242034 Figure 22: Africa GLP-1 Targeted Peptide Weight Loss Drugs Market Share, by Segments, 20242034

doi: 10.1089/ars.2012.5052 29 HernndezJ
In chondrocyte cultures, GHK-Cu increased the expression of type II collagen, the main structural protein of hyaline cartilage, as well as aggrecan, the most important proteoglycan for the compressive resistance of articular cartilage